MARKET

ANIK

ANIK

Anika
NASDAQ

Real-time Quotes | Nasdaq Last Sale

37.39
+1.92
+5.41%
After Hours: 37.39 0 0.00% 16:01 02/25 EST
OPEN
35.60
PREV CLOSE
35.47
HIGH
38.35
LOW
35.13
VOLUME
151.44K
TURNOVER
--
52 WEEK HIGH
47.48
52 WEEK LOW
22.01
MARKET CAP
531.48M
P/E (TTM)
-118.6984
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Viscosupplementation: Global Market Overview
Feb 25, 2021 (Heraldkeepers) -- COMTEX_381712176/2582/2021-02-25T07:42:32 Is there a problem with this press release? Contact the source provider Comtex at...
Heraldkeepers · 12h ago
Hemostat Market Poised for Growth | Key Players – Anika Therapeutics, BiomUp SAS.
Feb 24, 2021 (The Expresswire) -- The HEMOSTAT Market by revenue is expected to grow at a CAGR of over 6.5% during the forecast period 20202027 and is poised...
The Express Wire · 1d ago
Skin Tears Therapeutics Market Global Market Growth, Size, Trends, Insights and 2027 Forecast By Ameco Research
pune, India, Wed, 24 Feb 2021 06:20:10 / Comserve Inc. / -- Skin Tears Therapeutics market to help players in achieving a strong market position. Buyers of...
Comserve · 1d ago
Facial Injectable Market Size, Share and Growth to surpass USD 18,819 Mn by 2026
Feb 24, 2021 (Market Insight Reports) -- Global facial injectable market size is expected to exceed USD 18,819.04 Million by 2026, according to the latest...
Market Insight Reports · 1d ago
Biological Bone Repair Materials Market Size Research Report 2021 by Growth Rate, Revenue Estimates, Market Dynamics, Industry Trends and Forecast to 2027 Says Absolute Reports
Feb 24, 2021 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." “Biological Bone Repair Materials Market”...
The Express Wire · 1d ago
Emergency Hemostatic Agent Market Competitors Analysis from 2020 to 2027: Ameco Research
pune, India, Wed, 24 Feb 2021 02:19:38 / Comserve Inc. / -- The "Emergency Hemostatic Agent Market Outlook to 2020-2027" report has been added to the Ameco...
Comserve · 1d ago
Facial Injectables Market Forecast Analysis with Industry Size 2021: Growth Challenges, Competition by Top Companies, Regional Analsysi with Industry Share Outlook 2024
Feb 24, 2021 (The Expresswire) -- Global “Facial Injectables Market” trend report covers vital factors about the marketplace, profitability, competitive...
The Express Wire · 1d ago
Dermal Fillers Market 2031 Size, Industry Share, Growth, Trends and Top Key Players: Galderma Pharma S.A, Sinclair Pharma plc, Zimmer Biomet Holdings, Allergan plc, Anika Therapeutics Inc.
Markitwired · 2d ago
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ANIK. Analyze the recent business situations of Anika through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average ANIK stock price target is 52.00 with a high estimate of 61.00 and a low estimate of 43.00.
EPS
Institutional Holdings
Institutions: 294
Institutional Holdings: 15.05M
% Owned: 105.91%
Shares Outstanding: 14.21M
TypeInstitutionsShares
Increased
40
584.06K
New
39
4.42K
Decreased
69
633.98K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
-0.83%
Pharmaceuticals & Medical Research
-1.34%
Key Executives
President/Chief Executive Officer/Director
Cheryl Blanchard
Chief Financial Officer/Executive Vice President/Treasurer
Michael Levitz
Executive Vice President/General Counsel/Secretary
David Colleran
Executive Vice President/Director of Human Resources
Thomas Finnerty
Executive Vice President
James Loerop
Independent Director
John Henneman
Independent Director
Raymond Land
Independent Director
Glenn Larsen
Independent Director
Jeffrey Thompson
Independent Director
Stephen Richard
Independent Director
Jeffery Thompson
Independent Director
Susan Vogt
  • Dividends
  • Splits
  • Insider Activity
No Data
About ANIK
Anika Therapeutics, Inc. is a joint preservation company. The Company creates and delivers advancements in early intervention orthopedic care. It partners with physicians and develops minimally invasive products. It focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair and bone preserving joint technologies. Its product categories include joint pain management therapies, orthopedic joint preservation and restoration care, and other. The joint pain management therapies offer injectable viscosupplement products that provide pain relief from osteoarthritis conditions and its products include MONOVISC, ORTHOVISC, CINGAL and HYVISC. The Company's orthopedic joint preservation and restoration care products include HYALOFAST and TACTOSET. It also offers a line of surgical implant and instrumentation solutions that are used by surgeons to repair and reconstruct damaged ligaments and tendons due to sports injuries, trauma and disease.

Webull offers kinds of Anika Therapeutics Inc stock information, including NASDAQ:ANIK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANIK stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ANIK stock methods without spending real money on the virtual paper trading platform.